Article Text
Letter
Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma
Statistics from Altmetric.com
Footnotes
Funding: Foundation Fighting Blindness, Owings Mills, Maryland, USA; Dean’s Grant Support, University of Florida, Jacksonville, Florida, USA. Study sponsors did not participate in the study design, the collection, analysis and interpretation of data, the writing of the report, or the decision to submit the paper for publication.
Competing interests: None.
Ethics approval: From the local University of Florida IRB.
Patient consent: Obtained.